Top Marijuana Shares in the NASDAQ

Top Marijuana Shares in the NASDAQ

Top Marijuana Shares in the NASDAQ

Even though the almost all U.S.-based cannabis organizations and several foreign American Depository Receipts (ADRs) trade on the countertop (OTC), several cannabis organizations are exchanged regarding the NASDAQ. Some investors prefer stocks which are noted on the NASDAQ to many other exchanges for their increased liquidity and tighter spreads compared to the over-the-counter areas. For instance, given that cannabis industry is continuing to grow in recent months and years, uplisting from an OTC market to an established U.S. change is actually an advertising achievement for all marijuana that is rising. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis Stocks”)

An number that is increasing of organizations are now being noted on reputable U.S. exchanges rather than being traded regarding the OTC market showing the fast growth of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ ended up being the initial exchange that is electronic is certainly similar to technology and biotechnology. The cannabis organizations from the NASDAQ mirror this, while the greater part of them run into the biotech area of this industry. Here you will find the NASDAQ-listed cannabis shares, in alphabetical order, at the time of October 26, 2019, with a dysfunction of the total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is a biotech business active in the production of medical cannabis drugs. Research and development around Arena’s APD371 may be the main focus associated with firm’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is a check this is certainly blank that is currently in a merger agreement with Kalyx developing Inc. Kalyx is a number one owning a home rely upon the regulated cannabis industry in america.

Key Takeaways

  • The cannabis industry, specially the part of cannabis and biotech, is attracting investor attention that is substantial.
  • Cannabis will be found in brand brand new drugs for the treating discomfort and numerous chronic, inflammatory, and fibrotic conditions.
  • Businesses will also be developing cannabinoid services and products for autism spectrum disorders, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (a hereditary condition), and addiction that is amphetamine.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing new chemical entities for the indications of discomfort and pruritus (itching). Although all the firm’s clinical-stage services and products target opioid receptors, Cara is performing research that is preclinical cannabinoids to treat neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is just a cannabis biotech company. The group’s research, development, and production are based around cannabis medications that seek to take care of chronic, inflammatory, fibrotic, and other conditions.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is a cannabis that are canadian. The group has and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced plans to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to invest in its continued expansion but additionally with a well-established partner skilled within the advertising of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis business. It distributes a number of cannabis usage add-ons and vaporization equipment and items to retail clients in the U.S. and Canada. Furthermore, it runs websites that are e-commerce extra product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is developing a profile of cannabinoid medications. These medicines consist of Sativex for the treating spasticity linked to sclerosis that is multiple cancer tumors discomfort and Epidiolex for the treating youth epilepsy. Sativex is commercialized much more than the usual dozen nations cbt oil away from united states of america and contains gotten approval that is regulatory various other nations. Epidiolex received Food And Drug Administration approval being a therapy for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very very early beginning epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing cannabinoid items for autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is really a clinical-stage biopharmaceutical company that is developing medications according to its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally responsible bio-based pest administration and plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now legal for use on cannabis crops within the California cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern age Beverages Corp. is just a maker of beverages produced from yerba mate, green tea leaf, kombucha, and similar items. In recent months, modern age has expanded its beverage offerings to add CBD infusions also, bringing it to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in might of 2019, which makes it perhaps one of the most current cannabis businesses to record from the popular exchange. The organization happens to be quickly expanding its manufacturing capability and could manage to create just as much as 113,000 kilograms of product per by the end of 2019 year.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs into the enforcement sector. The company’s business operations support medication screening through hair samples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is yet another new entry on the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) when it announced the production of a fresh Palmetto make of leisure cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is a specialty clinical-stage company that is pharmaceutical in the growth of cannabinoid-based medications. Therapix’s present pipeline includes services and products targeted for the treating Tourette problem and mild intellectual disability.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. had been initial company that is marijuana-related have a preliminary general general public offering (IPO) in the usa. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis items.

Village Farms Global (NASDAQ:VFF)

Village Farms Global is the most cannabis that are recent to begin dealing from the NASDAQ. The company’s stocks became designed for trade on 21, 2019 february. The business possesses history that is decades-long greenhouse produce production and it has just recently shifted a number of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is focused in the development of synthetic treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline presently includes two medications being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.

Leave a Reply

Your email address will not be published. Required fields are marked *